{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-035110","form_type":"8-K","ticker":"FOXO","cik":"0001812360","company_name":"FOXO TECHNOLOGIES INC.","filed_at":"2026-07-29T12:35:11+00:00","discovered_at":"2026-07-29T12:40:01.373478+00:00","generated_at":"2026-07-29T12:42:21.549478+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"FOXO subsidiary Vector BioSource to acquire four blood collection centers from Grifols","bullets":["Acquisition structured as asset purchase with upfront cash and potential earnout based on EBITDA targets in 2026-2028.","Expected to add over $10M in net revenues in 12 months post-closing from sale of whole blood, serum, and other bio-samples.","Closing anticipated in Q3 or Q4 2026, subject to FDA licensure and other regulatory authorizations.","Acquisition intended to provide proprietary bio-products and expand Vector's accessible market via new FDA licensure.","Vector CEO cites milestone in evolving from biospecimen sourcing to integrated biospecimen solutions company."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-035110","json":"https://secwatch.observer/filing/0001493152-26-035110.json","markdown":"https://secwatch.observer/filing/0001493152-26-035110.md","text":"https://secwatch.observer/filing/0001493152-26-035110.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812360/000149315226035110/0001493152-26-035110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812360/000149315226035110/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-29T12:42:21.549478+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}